chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Chest X-ray normal, Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: Narrative: 56 y.o. male who presents for evaluation of chest tightness and dyspnea of 6 days duration. He received the first dose of the moderna vaccine and then the first dose of the pfizer vaccine. After this second dose he developed chest pain and shortness of breath. He is still able to exercise without significant limitations. He has no personal history of lung disease or heart disease. ECG without ischemic changes and troponin negative. CXR without acute findings. No leukocytosis or other significant lab abnormality. D dimer was mildly elevated and CTA significant for no PE.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Fibrin D dimer increased, Laboratory test normal, Troponin normal
Clinical narrative: Narrative: 56 y.o. male who presents for evaluation of chest tightness and dyspnea of 6 days duration. He received the first dose of the moderna vaccine and then the first dose of the pfizer vaccine. After this second dose he developed chest pain and shortness of breath. He is still able to exercise without significant limitations. He has no personal history of lung disease or heart disease. ECG without ischemic changes and troponin negative. CXR without acute findings. No leukocytosis or other significant lab abnormality. D dimer was mildly elevated and CTA significant for no PE.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Narrative: Patient received vaccine on 03/10/21. Patient was seen in urgent care healthcare professional on 04/05/21 " Patient complains of rash to left arm, and thighs that is itchy. reports office has been there since getting 1st dose of covid vaccine on 3/10/21". Steroids given; Patient had derm consult completed on 04/5/21 where it was recommended not to received second vaccination. Patient was unable to be contacted with his information prior to getting the second vaccination on 04/07/21. Patient contacted clinic reporting " Patient stated she took steroids shot and prednisone for 5 days. Rash went away and now is back after the medication stopped. " Comment on the report: entire body rash, resolved w/steroid's, had 2nd vaccine 4/7/21, and its back entire body. Derm consult entered. Consult indicated "Chief Complaint: Rash, s/p COVID vaccine. Patient took course of steroids which cleared rash. Team attempted to advise against receiving 2nd vaccine, but veteran took vaccine before speaking with team, Rash has returned.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Chest pain, Dyspnoea
Clinical narrative: Narrative:  Patient received full Pfizer COVID-19 vaccine series with 1st dose on 1/21/21 (lot: EL3302) and 2nd dose of 2/11/21 (lot: EN6201). On 4/29/21 patient sent to ED with shortness of breath, chest pain, weakness and headache. CT scan showed groundglass pattern consistent with COVID pneumonia. COVID test resulted as positive on 4/29/21. Patient admitted to general medicine ward. Patient oxygen saturation decreased requiring initiation of supplemental O2. Patient placed on dexamethasone 6mg oral daily x 10 days and remdesivir 200mg IV x 1 followed by 100mg daily for 5 days total duration. Local health department contacted to coordinate specimen collection and send off for further testing.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Lung opacity, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received full Pfizer COVID-19 vaccine series with 1st dose on 1/21/21 (lot: EL3302) and 2nd dose of 2/11/21 (lot: EN6201). On 4/29/21 patient sent to ED with shortness of breath, chest pain, weakness and headache. CT scan showed groundglass pattern consistent with COVID pneumonia. COVID test resulted as positive on 4/29/21. Patient admitted to general medicine ward. Patient oxygen saturation decreased requiring initiation of supplemental O2. Patient placed on dexamethasone 6mg oral daily x 10 days and remdesivir 200mg IV x 1 followed by 100mg daily for 5 days total duration. Local health department contacted to coordinate specimen collection and send off for further testing.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Cerebrovascular accident, Dysarthria, Magnetic resonance imaging head abnormal, Neurological symptom
Clinical narrative: Narrative:  On 9/21/2020 patient experienced an acute stroke after receiving recombinant zoster vaccine (2nd dose) on 9/14/2020. MRI showed left cerebllar/post left pons/rt occipital lobe acute stroke. Patient continued to experience left sided residuals and dysarthria at follow-up with pcp on 4/28/21. Unknown if caused by recombinant zoster vaccine but happened in such close proximity to getting dose that it seemed important to report.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Narrative: COVID infection requiring hospitalization in a fully vaccinated individual
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Intensive care
Clinical narrative: Narrative:  Death due to COVID infection in ICU in fully vaccinated individual
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Axillary vein thrombosis, Peripheral swelling, Subclavian vein thrombosis
Clinical narrative: Narrative:  LUL DVT (subclavian and axillary vein) in same arm; received **JANSSEN** Covid-19 Vector-NR vaccine on 3/9/21; onset of LUL swelling ~4/22/21. NO thrombocytopenia associated with clot. Hospitalized for anticoagulation initiation. Stable for discharge 4/29. Heparinoids used for treatment of clot.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: asymptomatic positive test after being fully vaccinated
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle fatigue, Pain, Rash
Clinical narrative: Narrative: patient reported continued muscle fatigue and body aches continued after receiving his 2nd dose of vaccine. Also had some bilateral rash to legs.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia
Clinical narrative: Narrative: COVID infection, severe COVID pneumonia requiring hospitalization in a fully vaccinated individual
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Narrative: He notes having experienced nausea that started about 2 hours after the initial vaccination and spontaneously resolved after about 1-2 hours without intervention. During that time, he was able to eat and drink without difficulty. He denied experiencing other adverse effects including vomiting abdominal cramping and diarrhea.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Depression
Clinical narrative: Narrative: Patient reports severe depression lasting 3 days after vaccination.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Narrative: She notes having developed nausea about 12 hours after the initial vaccination, which lasted for about a day. During that time, she took acetaminophen. She denied other adverse effects including vomiting, abdominal cramping and diarrhea. No therapies were applied or tried. She was able to tolerate oral intake during episode.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Narrative: Patient contacted PCP to report tinnitus began around same time as second Covid Vaccine. Patient also started losartan around this  time and has been taking OTC NSAIDS
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Feeling abnormal, Feeling cold, Headache
Clinical narrative: Narrative:  Patient contacted telephone triage nurse today requesting advice. States he received his second Moderna vaccine yesterday, "Around midnight I just started shaking uncontrollably, it was awful-couldn't get warm and I was having convulsions. " Patient states he is now experiencing body aches, " very bad headache", nausea and still experiencing chills. Temperature 98.6 at this time Also c/o low back pain " just feel horrible.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Seizure, Tremor
Clinical narrative: Narrative:  Patient contacted telephone triage nurse today requesting advice. States he received his second Moderna vaccine yesterday, "Around midnight I just started shaking uncontrollably, it was awful-couldn't get warm and I was having convulsions. " Patient states he is now experiencing body aches, " very bad headache", nausea and still experiencing chills. Temperature 98.6 at this time Also c/o low back pain " just feel horrible.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hepatocellular carcinoma
Clinical narrative: Narrative:  Death on 5/13/2021 approximately 3 months after 2nd dose of Pfizer vaccine. 68-year-old patient admitted to hospital for hospice/end of life care on 04/15. Newly diagnosed with hepatocellular carcinoma, with very limited treatment options, declining further life-prolonging therapy. No indication that death was due to vaccine
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative:  Timing error only. No ADR. Patient received 2nd dose 14 days after 1st dose due to scheduling error.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: pt passed away within 42 days of receiving the vaccine - unknown as to what lead to death
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Narrative: Error only. No ADR. Pt received 3 doses if Pfizer vaccine. 2 were received at Clinic (02/19, 03/20) and 1 at another facility (05/04)
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  pt received covid vaccine. pt passed away within 42 days of getting vaccine - pt passed away in his sleep- unknown correlation with vaccine
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Aspiration, COVID-19, Computerised tomogram thorax abnormal, Dyspnoea, Hypoxia
Clinical narrative: Narrative:  Patient received one dose of covid vaccine. Soon after LTC covid outbreak occurred, patient tested covid positive 5 days after first dose of vaccine. PMH Parkinsons, A fib dementia from with COVID-19 dx and stable until 1/10 and became progressively more hypoxic, CT showed RLL opacity c/w aspiration and started on cefepime 1/11. Patient is DNR/DNI and transferred to MICU last night for worsening hypoxia/work of breathing and frequent oral suctioning needs.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Lung opacity, Oropharyngeal suctioning, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Patient received one dose of covid vaccine. Soon after LTC covid outbreak occurred, patient tested covid positive 5 days after first dose of vaccine. PMH Parkinsons, A fib dementia from with COVID-19 dx and stable until 1/10 and became progressively more hypoxic, CT showed RLL opacity c/w aspiration and started on cefepime 1/11. Patient is DNR/DNI and transferred to MICU last night for worsening hypoxia/work of breathing and frequent oral suctioning needs.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hypercapnia, Hypothermia
Clinical narrative: Narrative: Hypothermia, Hypercarbia - pt was treated at outside hospital. pt passed away within 42 days of getting vaccine
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness unilateral
Clinical narrative: Narrative: Patient received first Moderna COVID-19 vaccine on 1/7/21. Patient was monitored for 15 minutes after the dose and had o reported side effects. Patient received second Moderna COVID -19 Vaccine on 2/4/21. Patient was monitored for 15 minutes after the dose and left the facility without any reported side effects. On 5/11/21, patient reported loss of vision to left eye for 10 minutes after second COVID-19 vaccine. Reports occurred about 30 minutes after dose. Optometry visit scheduled for patient.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dehydration, Diarrhoea
Clinical narrative: Narrative: Pt. received 2nd dose of Pfizer COVID-19 vaccine on March 8, 2021 and soon afterwards developed diarrhea. Was admitted to hospital 3/11/21 with generalized weakness and dehydration, likely due to diarrhea. Quickly resolved with IV fluid administration.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Narrative:  Patient is a 91 yo male who developed COVID-19 PNA after his first dose of the vaccine. Recovered after treatment (supportive care) during hospital admission.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Intensive care
Clinical narrative: Narrative:  Patient was admitted with severe COVID-19 requiring ICU admission after completing the full vaccine series > 2 weeks prior. Of note, patient does have CLL.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Narrative: Found to be COVID-19 Positive on3/9/2021 after first COVID-19 Vaccine on 3/5/2021. Was admitted for COVID-pneumonia on 3/14. After supportive therapy, patient was discharged on 3/16/21. Received 2nd dose on 3/26/21.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Narrative:  64 yo male with hx of HTN, joint pain, allergic rhinitis and asthma reported having SOB and chest tightness 4-5 hours after receiving Pfizer vaccine (2/8/2021). Pt reported this ADR on 3/1, when he returned for his second vaccine.  Both vaccines were administered without complications.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Immunisation reaction, Injection site erythema, Injection site mass, Injection site swelling
Clinical narrative: Narrative:  39 yo female with PMH GERD, DM2, Crohn's disease, obesity, and  plantar fasciitis who presented to urgent care on 3/15/2021 due to swelling and  erythema of injection site along with a lump under her arm where she received her second dose of pfizer. Patient received her first dose on 2/20 with no issue. She received the second dose on 3/12/2021. #LAD secondary to COVID vaccine- Patient with erythema and tenderness and lymphadenopathy consistent with  reaction to COVID vaccine. - No systemic symptoms at this point, though erythema has progressively increased since Friday. -Favor adverse reaction to vaccine vs.  cellulitis or abscess at this point Plan: -Symptomatic cares at this point, tylenol,  ice, rest. -Prescribed lidocaine patch for pain, apply 12 hours on/12 hours off. -No antibiotics at this time, instructed patient to return to clinic if begins developing  fevers or other systemic symptoms or purulent discharge. - If patients returns, would favor initiating antibiotics
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Tenderness
Clinical narrative: Narrative:  39 yo female with PMH GERD, DM2, Crohn's disease, obesity, and  plantar fasciitis who presented to urgent care on 3/15/2021 due to swelling and  erythema of injection site along with a lump under her arm where she received her second dose of pfizer. Patient received her first dose on 2/20 with no issue. She received the second dose on 3/12/2021. #LAD secondary to COVID vaccine- Patient with erythema and tenderness and lymphadenopathy consistent with  reaction to COVID vaccine. - No systemic symptoms at this point, though erythema has progressively increased since Friday. -Favor adverse reaction to vaccine vs.  cellulitis or abscess at this point Plan: -Symptomatic cares at this point, tylenol,  ice, rest. -Prescribed lidocaine patch for pain, apply 12 hours on/12 hours off. -No antibiotics at this time, instructed patient to return to clinic if begins developing  fevers or other systemic symptoms or purulent discharge. - If patients returns, would favor initiating antibiotics
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Myalgia, Nausea, Pyrexia
Clinical narrative: Narrative: Day of shot pt reports nausea and resolved that evening. pt reports pain at injection site the next day after the shot and self resolved within 3 days. Muscles aches on day 2 took Ibuprofen and resolved that day. Fatigue on day 3 followed by a fever on day 4 which self resolved that day.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Immediate post-injection reaction
Clinical narrative: Narrative:  53 yo male with PMH of glaucoma, OSA, degenerative joint disease of shoulder, HLP, chronic pain, hemorrhoids, irritable bowel, rectal bleeding,  SAD, fibromyalgia reported feeling warm immediately after his second pfizer dose of vaccine. Temp 99.5; Baseline 97, BP131/72, HR 86, RR 16, 98% O2.  Patient did not have this reaction with first dose of covid-19 vaccine given on 2/12/2021 (pfizer). Symptom self-resolved.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Covid infection following completion of COVID vaccine series 12/30 COVID vaccine dose #1 01/20 COVID vaccine dose #2 05/15 tested for COVID as part of pre-op preparation, COVID test positive, no symptoms.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: Narrative: 67 yo male developed hypotension after his 1st and only dose of Jansen Covid -19 vaccine. Hypotension resolved after oral fluid ingestion.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Narrative: Veteran reported diarrhea the day after his first pfizer vaccination  x2-3 days. Symptoms self-resolved. Pt reported this ADR when he came back for his second dose on 3/17/2021. Both doses were administered without complications.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Pain
Clinical narrative: Narrative:  82 yo male reported injection site pain, fatigue and body aches after his first dose of pfizer vaccine on 2/16/2021. Pt reported these ADRs when he  returned for his second vaccine on 3/9/2021. Both vaccines were administered without complications.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Headache, Sinus congestion
Clinical narrative: Narrative: 76 yo with unknown past medical history reported having headache with some sinus congestion the day his covid-19 pfizer vaccine on 2/8/2021. He said he also felt a "little confused" but the headache and confusion resolved the following day. Patient reported this ADR when he came back for his second dose on 3/1/2021, both vaccines were administered without complication.
Age: 100.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 98yo male patient with CAD s/p CABG, CVA with left-sided weakness, expressive aphasia and seizure s/p recent hospitalization AKI and Staph Epidermis bacteremia with likely source Endocarditis +/- pacemaker lead infection. Died while in hospice, no additional report to cause of death. Patient received one dose of the covid vaccine over two weeks prior to passing.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Neuropathy peripheral, Swelling face, Vaccination site reaction
Clinical narrative: 61 Y/o female with PMH DM2, HLP, OA, peripheral neuropathy, lumbosacral radiculopathy, PTSD, fatigue, GERD, asthma, allergic rhinitis, migraine, monopoiesis-arm, HTN, hypothyroidism, and hx of multiple nodules of lung called triage to inform the clinic of her ADR to Moderna Vaccine n 3/15/2021. PT received both Moderna on 2/13 and 3/13/ Patient reported that she "Reacted badly" to the COVID vaccine over the weekend and will not any future booster have shot. She reported that her face swelled up, body temp dropped to 94-plus, she could hardly breathe and her 02 sat level dropped into the 80's and RA (her normal range is 91-98% RA). Stated that because of her " Neuropathy and nerve damage" she couldn't not tell that she was having an allergic reaction. Did not realize that her face was swollen until she looked in the mirrow. Per Patient, it took her 2 days to get body temp and 02 Sat's back up to normal and for facial swelling resolve. Patients' shard that she has had the Covid infection (tested positive 11/9/2020 and believes her reaction to the vaccine was worse than the actual infection. She is eating, drinking, breathing and speaking without difficulty today. Denied symptoms all the time of her call to triage line on 3/13. Patient did not have to seek medical care.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Narrative:  69 yo male with PMH tobacco use, TIA, cataract, OSA, HTN PUD,  HF with EF 20-25% reported having diarrhea for 4 days after his first dose of covid-19 Pfizer vaccine on 2/8/2021. Symptoms self-resolved after 4 days. Pt did not seek medical care per record. Patient reported this ADR on 3/1/2021 when he  came back for his second dose of vaccine. Both vaccines were administered without complications.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for dyslipidemia, edema, barrett's esophagus, vitamin d3 deficiency, solitary nodule of lung, chronic airway obstruction, HTN, obesity, b12 deficiency, nondependent alcohol abuse, peripheral nerve disease. Per note 5/11, patient found deceased in apartment as a result of cardiac arrest. No cause of death listed or any other information.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Toxicologic test
Clinical narrative: Narrative: Patient received one dose of covid vaccine. Found deceased in home a couple weeks after. This is a 68 yo man with hx of multiple psychiatric comorbidities, newly diagnosed copd, htn, hld, cirrhosis of the liver. Wife concerned for drug use, requested toxicology report- results unknown to writer.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Malnutrition, Weight decreased
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for carcinoma of floor of mouth, COPD, malignant neoplasm of colon, ocular HTN, hyperlipidemia, hx of cerebrovascular accident, abnormal imaging of lung, nicotine dependence. Pt has a Smoking pack year of 100. Pt was scheduled for a g tube placement on 5/13 due to malnutrition and weight loss. Deceased on 5/10 under hospice care with no cause of death listed.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: NARRATIVE: Patient received his first dose of the COVID 19 vaccine on 2/18 and subsequently developed cough and shortness of breath. Tested positive for COVID 19 on 3/10. Prior negative test on 2/8. Patient was not hospitalized; recovered and received 2nd dose on MARCH 31, 2021.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Skin laceration, X-ray
Clinical narrative: Narrative:  Resulted in patient fall and skin tear to left  elbow. Required Xray to rule out fracture.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Metastatic neoplasm
Clinical narrative: Narrative:  Patient received two doses of covid vaccine. Patient found deceased in home approx. one month later. no further documentation of cause of death. patient with active metastatic disease.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Deep brain stimulation, Device related infection, Medical device removal, Swelling
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any  predisposing factors(PMH, allergies, ect.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for carcinoma of prostate, parkinson's disease, CAD s/p PCI and  Stenting, hyperlipidemia, impaired fasting glycaemia. Pt was on antibiotics starting around 2/16 for a "bump over the right extension" and treated with bactrim ds x 21 days. Pt admitted to outside facility acute inpatient care center for infection of deep brain stimulator on 3/30/21. Scheduled for 3/31 removal of DBS. Deceased on 4/3 with no cause of death listed.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Pneumonia
Clinical narrative: Narrative: Patient received two doses of covid vaccine. Patient died some time after at outside hospital. Admitted for PNA. PMHx significant for CAD hx of stent x 3 (2000 & 2012), Hyperlipidemia, HTN, end stage/severe COPD on continues home oxygen dependent, Hyperthyroidism, macular degeneration. No further details of death.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient with two doses of covid vaccine. Death reported thus submitting per network guidance. Patient with PMH of HFrEF s/p AICD, HTN, CAD, CKD, COPD, and neuroendocrine tumor. Patient had autopsy requested on March 3rd, 2021. No direct reactions reported related to vaccine.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received two doses of covid vaccine. Death occurred weeks after. Reporting per ISN 5 criteria. Patient with progressive dementia. Unclear cause of death, no further reports noted.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Neoplasm malignant
Clinical narrative: Narrative: Patient with one dose of COVID VACCINE. Patient with active malignancy proceeding to hospice. Patient died at outside hospital, no further documentation of death. Reported due to network 5 guidance.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: Covid (+) 03/29 after receiving 1st dose of COVID vaccine (03/05/21). Scheduled to receive 2nd dose 04/01/21.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Reporting per Network guidance. Patient with 1 dose of covid vaccine. PMH h/o CAD s/p CABG (SVG to PDA 3/2008, LIMA to LAD, Radial to OM, transmyocardial revascularization of inferior wall 9/2008), multiple coronary stents, atrial fibrillation on Warfarin, DM Type II, severe COPD on home O2, and SCC of the lung s/p RUL lobectomy with newly diagnosed metastatic changes from 12/2019. Limited details of death documented.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hyperlipidemia, advanced age, prostate cancer, CAD, HTN. Patient presented to Emergency facility, outside entity, on 5/3/2021 with a CC of SOB. Deceased on 5/5 with no notation of death or cause of death. Limited information available. Only one dose of Moderna Covid Vaccine is documented.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Decreased appetite, Device malfunction, Dialysis
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for sleep apnea, pleural effusion, chronic systolic heart failure, esrd, diastolic heart failure, ckd stage 5, dyslipidemia , anemia, renal failure, obesity. Patient was on palliative care. Per note 5/7 "He was hospitalized in hospital 4/13-4/14/21 due to a non-functioning dialysis catheter. He has been sick much of the time since his IJ catheter was placed 9/22/20 and has not had a dialysis fistula placed. He has had multiple issues with his dialysis catheter due to clogging, including needing 3 ED visits, and had the clog dissolved most of the time. Nephrology successfully completed a dialysis session on 4/14 with removal of 7 pounds. He is being scheduled for an outpatient Vascular Surgery appointment to begin fistula creation. He was hospitalized in hospital 4/25-4/27/21 for management of volume overload. he was dialized on 4/26 and 4/27 without issues of catheter clogging. He had been planned for evaluation of his catheter but chose to return home and have the procedure as an outpatient. He was noted to have a R pleural effusion, but workup was deferred to PCP. He was discharged home after his volume status improved. His R IJ dialysis catheter was replaced 5/4/21. Per patient, it is now functioning normally. He met with his PCP on 5/6/21 for a followup. His wife reported concerns about his oxygen level, 92%. He does not use CPAP and sleeps when sitting rather than in bed. He is also craving salt and eating salt packets. He is not eating due to anorexia and he is not drinking supplements." Deceased 5/12 with no cause of death listed.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypervolaemia, Medical device change, Pleural effusion, Salt craving
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for sleep apnea, pleural effusion, chronic systolic heart failure, esrd, diastolic heart failure, ckd stage 5, dyslipidemia , anemia, renal failure, obesity. Patient was on palliative care. Per note 5/7 "He was hospitalized in hospital 4/13-4/14/21 due to a non-functioning dialysis catheter. He has been sick much of the time since his IJ catheter was placed 9/22/20 and has not had a dialysis fistula placed. He has had multiple issues with his dialysis catheter due to clogging, including needing 3 ED visits, and had the clog dissolved most of the time. Nephrology successfully completed a dialysis session on 4/14 with removal of 7 pounds. He is being scheduled for an outpatient Vascular Surgery appointment to begin fistula creation. He was hospitalized in hospital 4/25-4/27/21 for management of volume overload. he was dialized on 4/26 and 4/27 without issues of catheter clogging. He had been planned for evaluation of his catheter but chose to return home and have the procedure as an outpatient. He was noted to have a R pleural effusion, but workup was deferred to PCP. He was discharged home after his volume status improved. His R IJ dialysis catheter was replaced 5/4/21. Per patient, it is now functioning normally. He met with his PCP on 5/6/21 for a followup. His wife reported concerns about his oxygen level, 92%. He does not use CPAP and sleeps when sitting rather than in bed. He is also craving salt and eating salt packets. He is not eating due to anorexia and he is not drinking supplements." Deceased 5/12 with no cause of death listed.
Age: 97.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for advanced age, malnutrition, pulmonary embolism, anemia, hypertension, coronary atherosclerosis, hyperlipidemia, COPD. Patient was 95 years of age. No notation regarding death or cause of death. Deceased 5/15/2021.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Musculoskeletal chest pain, Oropharyngeal pain, Retching
Clinical narrative: Narrative:  COVID INFECTION following completion of COVID vaccine series and prior infection 11/17 COVID positive 02/22 COVID vaccine dose #1 03/15 COVID vaccine dose #2 05/10 symptoms started: coughing dry heaves, chest wall aches from coughing so much 05/12 presented for COVID testing due to 2 day h/o sore throat and myalgia, cough, resolution of chest wall ache
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID INFECTION following completion of COVID vaccine series and prior infection 11/17 COVID positive 02/22 COVID vaccine dose #1 03/15 COVID vaccine dose #2 05/10 symptoms started: coughing dry heaves, chest wall aches from coughing so much 05/12 presented for COVID testing due to 2 day h/o sore throat and myalgia, cough, resolution of chest wall ache
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID INFECTION FOLLOWING COMPLETION OF COVID VACCINE SERIES 01/25 COVID vaccine dose #1 02/16 COVID vaccine dose #2 05/15 COVID POSITIVE (tested as part of pre-op for colonoscopy), asymptomatic
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID POSITIVE FOLLOWING COMPLETING OF COVID VACCINE SERIES 01/13 COVID vaccine dose #1 02/04 COVID vaccine dose #2 02/22 pt tested for COVID as part of pre-procedure to start radiation therapy, tested positive, no symptoms 03/04 quarantine ended, remained asymptomatic 03/10 seen in ED due to fall (tangled feet in o2 tubing); tested positive for covid; admitted to r/o stroke 03/12 discharged from hospital 05/10 still testing COVID positive but no symptoms
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  Received 2 doses of Pfizer COVID vaccine( 2/4/21 and 2/25/21 and tested COVID + during dental pre-procedure screening. Only symptom reported in "dry Cough" on follow up call on 3/4/21.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Pneumonia aspiration, Wound, Wound closure, Wound infection
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for Obesity, Essential Hypertension, sleep apnea, parkinson's disease, t2dm. Received both Covid Pfizer vaccines at outside entity. Patient was placed in Home Care in April due to wound on coccyx and wound vac. Per note 5/12, patient was admitted to outside entity hospital, and had aspiration pneumonia and infection from wound on the coccyx. Was placed into hospice on 5/13.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received two doses of covid vaccine. Died approx. one month later. Unclear cause of death and no further reports of death documented. Patient with PMH of HFrEF, NSTEMI, COPD,CKD, AMS, HTN.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: Narrative:  mild cough probably unrelated, possible previous positive but unconfirmed.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Fluid intake reduced, Food refusal, Refusal of treatment by patient
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for cognitive impairment, glaucoma, anxiety, schizoaffective disorder, venous insufficiency, mitral regurgitation, lymphedema, elevated liver enzymes, hyperlipidemia, vitamin d deficiency, hypertension, cerebrovascular accident, seizure. Note 5/11 and 5/12 states that patient was in nursing home refusing food, drinks, and medications for 3 days. Patient also experienced seizure like activity as recent as 3 weeks ago. Patient also presented to ER on 5/3 s/p witnessed seizure. Patient deceased 5/15, found unresponsive by caregiver. No cause of death listed.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure, Seizure like phenomena, Unresponsive to stimuli
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for cognitive impairment, glaucoma, anxiety, schizoaffective disorder, venous insufficiency, mitral regurgitation, lymphedema, elevated liver enzymes, hyperlipidemia, vitamin d deficiency, hypertension, cerebrovascular accident, seizure. Note 5/11 and 5/12 states that patient was in nursing home refusing food, drinks, and medications for 3 days. Patient also experienced seizure like activity as recent as 3 weeks ago. Patient also presented to ER on 5/3 s/p witnessed seizure. Patient deceased 5/15, found unresponsive by caregiver. No cause of death listed.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: Patient received two doses of covid vaccine. Found deceased in home nearing one month after second vaccination. PMH included GAD/depression, ETOH/cannabis abuse, COPD, tobacco dependence, LE PVD, AAA (3.5 cm), colonic polyp, and hyperlipidemia. No further evaluation of death documented.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes, Overdose
Clinical narrative: Narrative:  Patient was hospitalized in med unit on 5/17/2021 d/t AMS 2/2 overmedication. Documenting VAERS d/t proximity of COVID-19 MODERNA vaccine and hospitalization. No reported ADR since vaccination.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive at the time (tested positive july 2020) and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for vitamin d deficiency, dvt hx, paralysis of intestine, organic brain syndrome, t2dm, hyperlipidemia, essential htn, dementia. Pt was 76 years of age, deceased under hospice care on 05/13/2021. No cause of death listed.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: None Stated.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt was 84 years of age, with a PMH significant for hyperlipidemia, HTN, stent for CAD, COPD. No notation of death listed, no recent issues or hospitalizations noted. Limited pt information available.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Death, Hyponatraemia, Loss of personal independence in daily activities
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for antineoplastic chemotherapy hx, htn, tobacco use, neoplasm of left upper lobe of lung, hypertriglyceridemia, htn, hypercholesterolemia, malignant neoplasm of intrathoracic lymph nodes. Per note 4/20/2021 "is a 79 y/o MALE is here for follow-up. He is not doing well. He was recently admitted to the hospital with small bowel obstruction and hyponatremia. No etiology was disocevered for his SBO. Hyponatremia improved with urea powder. Patient was discharfged to rehab on 4/15/21. He reports continuing to feel weak and also admits nausea and vomiting. Overall, he is bed-bound most of the day and requires assistance with all ADLs. He states he wishes to go home." patient deceased 5/2/2021 while under care of hospice.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Small intestinal obstruction, Vomiting
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for antineoplastic chemotherapy hx, htn, tobacco use, neoplasm of left upper lobe of lung, hypertriglyceridemia, htn, hypercholesterolemia, malignant neoplasm of intrathoracic lymph nodes. Per note 4/20/2021 "is a 79 y/o MALE is here for follow-up. He is not doing well. He was recently admitted to the hospital with small bowel obstruction and hyponatremia. No etiology was disocevered for his SBO. Hyponatremia improved with urea powder. Patient was discharfged to rehab on 4/15/21. He reports continuing to feel weak and also admits nausea and vomiting. Overall, he is bed-bound most of the day and requires assistance with all ADLs. He states he wishes to go home." patient deceased 5/2/2021 while under care of hospice.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any  predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient past medical history include DM1-II, Heart Failure, CAD, Osteoarthritis, A. Fibrillation, Hypoxemia Respiratory Failure, Heart Block. Per note on March 10th 20212, patient returned for ACA following hospitalization for fluid retention and cellulitis. No other relevant notes were find and also Pt was 78 years old.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event.  The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death.  PMH significant for HTN, CAD, chronic obstructive lung disease, tobacco use, vitamin d deficiency. 2nd pfizer covid vaccine status unknown, not documented. Was under the care of hospice at time of death, however no notation regarding cause of death available.
Age: 101.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 100 yo male with PMH COPD, BPH, Afib, OA, and GERD under hospice care (unsure of location) died on 4/12/2021, 4 days after his second Moderna vaccine dose on 4/8/2021. Pt received first dose on 3/12/2021. Both doses were administered without complications. This death is being reported since pt died within 42 days of the last covid-19 vaccine. No other information found in records regarding this death. Records only show that a family member called to notify the agency of patient's death.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Auscultation, Dizziness
Clinical narrative: Narrative: She reported feeling lightheaded to staff about 15 minutes after administration of the vaccination. Noted that she was feeling anxious about the vaccination and had not had a good night's rest prior. She denied itchiness,  urticaria, flushing, swelling, confusion/disorientation, dizziness/lightheadedness,  weakness, shortness of breath, palpitations, nausea abdominal cramping, or feeling the need to vomit/have diarrhea. She was able to eat an orange that she brought with her to clinic without difficulty. O: BP 18/98 initially-> 142/88 on repeat after ~10 minutes HR 86 RR 12 SpO2 96% on RA Gen: not in distress, answering questions appropriately, pleasant HEENT: atraumatic/normocephalic,  PERRL, nares patent, throat non-erythematous/no exudate Neck: no lymphadenopaty, no thyromegaly or carotid bruits CV: regular rate and rhythm,  normal S1/S2, no murmurs/heave/lifts. Radial and pedal pulses 2+ b/l Pulm: clear to auscultation bilaterally with no wheezes/rales/rhonci Abd: soft, non- tender/non-distended, +NBS in all 4 quadrants Ext: moves all 4 spontaneously, no edema Skin: no lesions or rashes Neuro: CN II-XII grossly intact, 5/5 strength UE and LE Psych: appropriate, thoughts linear and on-tangential A/P: 56 yo  with feelings of lightheadedness s/p initial vaccination. Normalized response and  feelings of anxiousness about vaccination. Explored and discussed concerns regarding vaccination, including differences b/t current vaccination option, as much as possible to provide further information/support. Lightheadedness improved during examination time. Offered that patient was able to stay as  long as she felt that she needed to s/p the 30 minutes observation time (2/2 h/o anaphylaxis to sulfa - allergy updated). At the end of her 30 minutes, she felt  well/ok to leave clinic. No further evaluation/follow-up needed. Education regarding common adverse effects and when to seek care (including when to seek emergent care) had been provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Condition aggravated, Death, Peripheral T-cell lymphoma unspecified, Rash
Clinical narrative: Narrative:  Developed rash 11 days after initial covid vaccine, progressed & ultimately determined he had developed an aggressive peripheral T-cell lymphoma and the patient died of cardiac arrest likely precipitated by the lymphoma. The rash I believe is the T-cell lymphoma
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for gout, CAD, essential HTN, hyperglycemia, AF, ckd stage 2, basal cell carcinoma, obesity, CHF. Pt was 86 years of age, with no notes of any recent hospitalizations or issues. No notation regarding death. Per database, received one dose of pfizer covid vaccine on 1/25/2021 at outside entity. No notation of 2nd dose received.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Influenza like illness
Clinical narrative: Narrative:  Patient received first COVID-19 vaccine dose on 3/26/21 and the second dose appropriately on 4/16/21. Following the second dose he experienced flu-like symptoms which he was counseled were normal symptoms following a vaccination. About 5 days later on 4/23/21, he reported to an outside hospital complaining of chest pain that was "0/10" at present time. No medications were  given.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Electroencephalogram normal
Clinical narrative: Narrative:  Provider documentation surrounding the event is provided under the events section above. Please reach out if further details are needed. Thank you!
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative: Patient was transferred to the hospital and release.